Skip to main content
TipRanks
Go Ultimate75% OFF

Essity Aktiebolag (ESW) Q3 2026 Earnings Report

2 Followers

DE:ESW Q3 2026 EPS Results

Actual EPS
EUR 0.45
Consensus EPS
EUR 0.40
Beat/Miss
Beat by +EUR 0.05
One Year Ago EPS
EUR 0.44

DE:ESW Q3 2026 Revenue Results

Actual Revenue
EUR 3.29B
Expected Revenue
EUR 3.30B
Beat/Miss
Missed by -EUR 8.64M
YoY Revenue Growth
+4.11%

Earnings Announcement Details

Quarter
Q3 2026
Date
10/22/2026
Time
Before Open
Conference Call
Thursday, October 22, 2026
DE:ESW Upcoming Earnings

Essity Aktiebolag's next earnings date is estimated for January 21, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Oct 22, 2026|% Change Since:4.19%|
Earnings Call Sentiment|Positive

The call conveyed cautious optimism. Essity demonstrated stable group volumes, reported sales growth, strong cash flow, a solid balance sheet, market-share gains and progress in higher-margin categories, acquisitions and cost savings. However, these positives were offset by negative organic sales growth, substantial COGS inflation, margin contraction, declining Consumer Tissue and Professional Hygiene volumes, and expectations for further cost pressure in Q4. Management remained confident in pricing actions, cost savings and strategic initiatives, but described the near-term market and cost environment as challenging.

Company Guidance

For Q4, Essity expects “significantly higher COGS” both year-on-year and sequentially, driven by raw material and energy costs; SG&A excluding A&P is expected to be “roughly on the same level or actually even slightly lower” than Q4 of 2025 and sequentially, with savings of “roughly about SEK 150 million or slightly more than SEK 150 million” in Q3 and Q4 savings expected to be “even bigger,” while A&P is expected to be “slightly higher” than this quarter. The company will continue announcing and negotiating new price increases, with Consumer Tissue taking “roughly 2 quarters to compensate”; the 1.2% volume impact from Latin American factory footprint optimization is expected to remain in Q4, Q1 and Q2 of 2027; Medical volume growth is anticipated to come back in Q4, although this is “difficult to guarantee”; the Brazilian Feminine Care transaction is expected to close by Q2 '27; and tariff impacts were estimated at “approximately about 60 basis points” for Professional Hygiene and “[ 20%, 30% ] basis points” for the group as a whole.

  • Resilient Overall PerformanceThe third quarter was characterized by resilience and stable performance in a challenging market. Group volumes were stable overall, supported by volume-led growth in higher-margin categories and segments.
  • Net Sales GrowthNet sales increased by approximately SEK 1.5 billion, or 4.1%, compared with Q3 2025. Currency contributed 2.5% and the North American Feminine Care acquisition contributed close to 2%.
  • Growth in Higher-Margin CategoriesThe company continued to see volume-led growth in incontinence care, Health & Medical, Feminine Care, Wound Care, incontinence care retail and premium Professional Hygiene products.
  • Health & Medical GrowthHealth & Medical continued to grow in both incontinence care and medical products, driven by higher prices and stable volumes. Wound Care and North America were highlighted as areas of particularly good growth.
  • Personal Care Market Share GainsBranded businesses in all three Personal Care categories gained market share. Incontinence Care and Feminine Care also achieved higher volume and sales growth, supported by marketing investments.
  • Feminine Care Expansion in BrazilEssity announced the acquisition of the o.b., Sempre Livre and Carefree brands in Brazil. Brazil is described as the fourth-largest Feminine Care market globally, growing at roughly 4%, and the transaction is expected to close by Q2 2027. The acquisition provides access to the retail channel and is expected to support further TENA growth.
  • North American Acquisition Integration ProgressIntegration of the North American Feminine Care acquisition continued, with margins improving step by step. Essity implemented a more direct sales model without business disruptions, and sales performance was progressing as expected.
  • North American Personal Care MomentumLeakproof apparel was described as performing very well in North America, while the TENA business continued to grow online and gain market share. Essity said its plan to grow TENA market share was yielding results and that the new go-to-market model should support further brick-and-mortar growth.
  • Latin American Feminine Care PositionEssity rolled out Smart Protect technology to the Feminine Care Night segment in Latin America, where it is already a strong market leader with over 60% market share.
  • Product InnovationEssity expanded the JOBST Elvarex Soft ready-to-wear range with new styles, sizes and body-part options for lymphedema patients. In Consumer Tissue, it upgraded the Regio assortment for greater softness and launched a larger, thicker moist toilet paper sheet that requires one sheet and dissolves faster.
  • Tork Vision Cleaning ExpansionTork Vision Cleaning can reduce customers' cleaning-operation time by up to 25%. The offering was present in 38 airports globally, with expansion into health care, stadiums and industrial customers. A BMW factory in the U.S. uses 3,500 connected devices, and 50% of Tork Vision Cleaning customers are new to Tork.
  • Cost-Saving Program ProgressSG&A contributed 20 basis points to margin, primarily through the cost-saving program. Savings were roughly SEK 150 million or slightly more in the quarter, with Q4 savings expected to be even larger. Management expects the program to deliver in line with or above its commitment.
  • Energy Savings and Manufacturing OptimizationEnergy savings totaled SEK 180 million, broadly in line with the full-year estimate. The Latin American manufacturing-footprint optimization is expected to generate annual savings of approximately SEK 150 million to SEK 160 million, or roughly USD 70 million, and management said the initiative is profitable from a profitability standpoint.
  • Strong Cash Flow and Balance SheetTotal cash flow was SEK 5.8 billion, supported by continued strong cash surplus and improved working-capital performance. Net debt was SEK 25 billion and net debt to EBITDA was 1.0, despite acquisitions, significant share buybacks and an increased dividend.
  • Sustainability RecognitionEssity was awarded EcoVadis Platinum again and was ranked among the top 1% of the 175,000 companies assessed worldwide.

DE:ESW Earnings History

DE:ESW earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Jan 21, 20272026 (Q4)0.42-0.43――
Oct 22, 20262026 (Q3)0.400.450.441.23% (+0.01)
Jul 16, 20262026 (Q2)0.400.360.4-10.25% (-0.04)
Apr 23, 20262026 (Q1)0.390.390.4-4.51% (-0.02)
Jan 22, 20262025 (Q4)0.440.430.3813.56% (+0.05)
Oct 23, 20252025 (Q3)0.430.440.432.75% (+0.01)
Jul 17, 20252025 (Q2)0.430.400.43-6.99% (-0.03)
Apr 24, 20252025 (Q1)0.420.400.3226.21% (+0.08)
Jan 23, 20252024 (Q4)0.460.380.41-9.03% (-0.04)
Oct 24, 20242024 (Q3)0.430.430.422.16% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed